- Home
- HURA vs WGRX Comparison
HURA vs WGRX Comparison
Compare HURA & WGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HURA
- WGRX
- Stock Information
- Founded
- HURA 2009
- WGRX 2022
- Country
- HURA United States
- WGRX United States
- Employees
- HURA N/A
- WGRX N/A
- Industry
- HURA
- WGRX Other Pharmaceuticals
- Sector
- HURA
- WGRX Health Care
- Exchange
- HURA Nasdaq
- WGRX Nasdaq
- Market Cap
- HURA 126.1M
- WGRX 111.0M
- IPO Year
- HURA N/A
- WGRX 2025
- Fundamental
- Price
- HURA $2.59
- WGRX $0.69
- Analyst Decision
- HURA Strong Buy
- WGRX
- Analyst Count
- HURA 2
- WGRX 0
- Target Price
- HURA $11.50
- WGRX N/A
- AVG Volume (30 Days)
- HURA 214.3K
- WGRX 1.2M
- Earning Date
- HURA 11-13-2025
- WGRX 11-11-2025
- Dividend Yield
- HURA N/A
- WGRX N/A
- EPS Growth
- HURA N/A
- WGRX N/A
- EPS
- HURA N/A
- WGRX N/A
- Revenue
- HURA N/A
- WGRX $36,738,599.00
- Revenue This Year
- HURA N/A
- WGRX N/A
- Revenue Next Year
- HURA N/A
- WGRX N/A
- P/E Ratio
- HURA N/A
- WGRX N/A
- Revenue Growth
- HURA N/A
- WGRX 82384.51
- 52 Week Low
- HURA $1.80
- WGRX $0.62
- 52 Week High
- HURA $8.40
- WGRX $7.04
- Technical
- Relative Strength Index (RSI)
- HURA 45.68
- WGRX 32.06
- Support Level
- HURA $2.38
- WGRX $0.64
- Resistance Level
- HURA $2.66
- WGRX $1.03
- Average True Range (ATR)
- HURA 0.12
- WGRX 0.13
- MACD
- HURA 0.01
- WGRX -0.05
- Stochastic Oscillator
- HURA 42.86
- WGRX 7.08
About HURA TuHURA Biosciences Inc. Common Stock
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.
About WGRX Wellgistics Health Inc. Common Stock
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. It is focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.